| Product Code: ETC9547365 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden AI In Oncology Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden AI In Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden AI In Oncology Market - Industry Life Cycle |
3.4 Sweden AI In Oncology Market - Porter's Five Forces |
3.5 Sweden AI In Oncology Market Revenues & Volume Share, By Component Type, 2021 & 2031F |
3.6 Sweden AI In Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Sweden AI In Oncology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Sweden AI In Oncology Market Revenues & Volume Share, By End-use Type, 2021 & 2031F |
4 Sweden AI In Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Sweden |
4.2.2 Growing adoption of AI technology in healthcare |
4.2.3 Government initiatives to promote AI in oncology research |
4.3 Market Restraints |
4.3.1 Data privacy and security concerns |
4.3.2 High implementation costs of AI technology |
4.3.3 Resistance from healthcare professionals to adopt AI solutions |
5 Sweden AI In Oncology Market Trends |
6 Sweden AI In Oncology Market, By Types |
6.1 Sweden AI In Oncology Market, By Component Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden AI In Oncology Market Revenues & Volume, By Component Type, 2021- 2031F |
6.1.3 Sweden AI In Oncology Market Revenues & Volume, By Software Solutions, 2021- 2031F |
6.1.4 Sweden AI In Oncology Market Revenues & Volume, By Hardware, 2021- 2031F |
6.1.5 Sweden AI In Oncology Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Sweden AI In Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden AI In Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Sweden AI In Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 Sweden AI In Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 Sweden AI In Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.6 Sweden AI In Oncology Market Revenues & Volume, By Brain TumorOthers, 2021- 2031F |
6.3 Sweden AI In Oncology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Sweden AI In Oncology Market Revenues & Volume, By Diagnostics (Pathology, Cancer Radiology), 2021- 2031F |
6.3.3 Sweden AI In Oncology Market Revenues & Volume, By Radiation Therapy (Radiotherapy), 2021- 2031F |
6.3.4 Sweden AI In Oncology Market Revenues & Volume, By Research & Development (Drug design, development process, etc.), 2021- 2031F |
6.3.5 Sweden AI In Oncology Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.3.6 Sweden AI In Oncology Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.4 Sweden AI In Oncology Market, By End-use Type |
6.4.1 Overview and Analysis |
6.4.2 Sweden AI In Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Sweden AI In Oncology Market Revenues & Volume, By Surgical Centers & Medical Institutes, 2021- 2031F |
6.4.4 Sweden AI In Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden AI In Oncology Market Import-Export Trade Statistics |
7.1 Sweden AI In Oncology Market Export to Major Countries |
7.2 Sweden AI In Oncology Market Imports from Major Countries |
8 Sweden AI In Oncology Market Key Performance Indicators |
8.1 Percentage increase in the number of AI-powered oncology research projects in Sweden |
8.2 Improvement in accuracy and efficiency of cancer diagnosis and treatment with AI |
8.3 Number of partnerships between AI companies and healthcare institutions for oncology research and development |
9 Sweden AI In Oncology Market - Opportunity Assessment |
9.1 Sweden AI In Oncology Market Opportunity Assessment, By Component Type, 2021 & 2031F |
9.2 Sweden AI In Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Sweden AI In Oncology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Sweden AI In Oncology Market Opportunity Assessment, By End-use Type, 2021 & 2031F |
10 Sweden AI In Oncology Market - Competitive Landscape |
10.1 Sweden AI In Oncology Market Revenue Share, By Companies, 2024 |
10.2 Sweden AI In Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here